2025
SJR Q1
JCR Q1 · 4,6
93 matched articles
SCIE
Journal detail
Endocrine Pathology
- Publisher
- Springer
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1046397615590097
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 3,715
- Quartile Q1
- H-Index 65
- Cites/doc 3,6
- Docs (3y) 139
- Cites (3y) 1.517
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,6
- 5Y JIF 8,9
- JCI 3,52
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Endocrinology Q1
- Endocrinology, Diabetes and Metabolism Q1
- Medicine (miscellaneous) Q1
- Pathology and Forensic Medicine Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Endocrinology & Metabolism | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 3,715 | 4,6 | 8,9 | 3,52 | Q1 | 65 |
| 2024 | Q1 | Q1 | 3,832 | 14,7 | 7,5 | 3,56 | Q1 | 61 |
| 2023 | Q1 | Q1 | 2,566 | 11,3 | 6 | 3,04 | Q1 | 61 |
| 2022 | Q1 | Q1 | 0,944 | 4,4 | 3,8 | 1,22 | Q1 | 61 |
| 2021 | Q1 | Q2 | 0,904 | 4,1 | 4 | 0,97 | Q2 | 61 |
| 2020 | Q1 | Q2 | 0,99 | 3,9 | 3,6 | 0,96 | Q2 | 61 |
| 2019 | Q1 | Q2 | 0,886 | 3,2 | 2,5 | 0,94 | Q2 | 61 |
| 2018 | — | Q1 | — | 3,4 | 2,5 | 0,85 | Q2 | — |
| 2017 | Q2 | Q2 | 0,734 | 2,5 | 2,2 | 0,77 | Q2 | 61 |
| 2016 | Q2 | Q3 | 0,531 | 1,9 | 1,8 | — | — | 61 |
| 2015 | Q2 | Q3 | 0,49 | 1,8 | 1,6 | — | — | 61 |
| 2014 | Q2 | Q3 | 0,579 | 1,8 | 1,7 | — | — | 61 |
| 2013 | Q2 | Q3 | 0,665 | 1,6 | 1,7 | — | — | 61 |
| 2012 | Q2 | Q3 | 0,643 | 1,6 | 1,5 | — | — | 61 |
| 2011 | Q2 | Q3 | 0,648 | 1,4 | 1,5 | — | — | 61 |
| 2010 | Q2 | Q3 | 0,652 | 1,6 | 1,8 | — | — | 61 |
| 2009 | — | Q3 | — | 1,4 | 1,9 | — | — | — |
| 2008 | — | Q3 | — | 1,6 | 1,6 | — | — | — |
| 2007 | — | Q2 | — | 1,8 | 1,8 | — | — | — |
| 2006 | — | Q3 | — | 1,5 | — | — | — | — |
| 2005 | — | Q3 | — | 1,1 | — | — | — | — |
| 2004 | — | Q2 | — | 1,7 | — | — | — | — |
| 2003 | — | Q4 | — | 0,9 | — | — | — | — |
| 2002 | — | Q4 | — | 0,4 | — | — | — | — |
| 2001 | — | Q4 | — | 0,5 | — | — | — | — |
| 2000 | — | Q4 | — | 0,4 | — | — | — | — |
| 1999 | — | Q4 | — | 0,6 | — | — | — | — |
| 1998 | — | Q4 | — | 0,6 | — | — | — | — |
| 1997 | — | Q2 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 55/198 |
| 2025 | PATHOLOGY | SCIE | Q1 | Q1 | 10/89 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 7/193 |
| 2024 | PATHOLOGY | SCIE | Q1 | Q1 | 2/90 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 8/186 |
| 2023 | PATHOLOGY | SCIE | Q1 | Q1 | 2/88 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 45/145 |
| 2022 | PATHOLOGY | SCIE | Q1 | Q1 | 19/76 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 75/146 |
| 2021 | PATHOLOGY | SCIE | Q2 | Q2 | 27/77 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 76/146 |
| 2020 | PATHOLOGY | SCIE | Q2 | Q2 | 24/77 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 76/143 |
| 2019 | PATHOLOGY | SCIE | Q2 | Q2 | 21/78 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 58/145 |
| 2018 | PATHOLOGY | SCIE | Q1 | Q2 | 19/76 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 91/142 |
| 2017 | PATHOLOGY | SCIE | Q2 | Q2 | 28/79 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 104/138 |
| 2016 | PATHOLOGY | SCIE | Q3 | — | 40/79 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 102/133 |
| 2015 | PATHOLOGY | SCIE | Q3 | — | 42/79 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 101/128 |
| 2014 | PATHOLOGY | SCIE | Q3 | — | 45/76 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 92/124 |
| 2013 | PATHOLOGY | SCIE | Q3 | — | 51/76 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 95/122 |
| 2012 | PATHOLOGY | SCIE | Q3 | — | 51/77 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 101/122 |
| 2011 | PATHOLOGY | SCIE | Q3 | — | 55/79 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 92/116 |
| 2010 | PATHOLOGY | SCIE | Q3 | — | 44/76 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 84/105 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 46/71 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 79/93 |
| 2008 | PATHOLOGY | SCIE | Q3 | — | 42/69 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 65/92 |
| 2007 | PATHOLOGY | SCIE | Q2 | — | 29/66 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 73/93 |
| 2006 | PATHOLOGY | SCIE | Q3 | — | 37/64 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 73/89 |
| 2005 | PATHOLOGY | SCIE | Q3 | — | 44/66 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 57/87 |
| 2004 | PATHOLOGY | SCIE | Q2 | — | 24/65 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 74/88 |
| 2003 | PATHOLOGY | SCIE | Q4 | — | 50/64 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 86/88 |
| 2002 | PATHOLOGY | SCIE | Q4 | — | 57/64 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 87/90 |
| 2001 | PATHOLOGY | SCIE | Q4 | — | 57/66 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 84/89 |
| 2000 | PATHOLOGY | SCIE | Q4 | — | 61/67 |
| 1999 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 76/85 |
| 1999 | PATHOLOGY | SCIE | Q4 | — | 52/66 |
| 1998 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 76/83 |
| 1998 | PATHOLOGY | SCIE | Q4 | — | 55/68 |
| 1997 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 52/81 |
| 1997 | PATHOLOGY | SCIE | Q2 | — | 32/66 |